Increased risk of hepatotoxicity in HIV-infected pregnant women receiving antiretroviral therapy independent of nevirapine exposure.

Increased risk of hepatotoxicity in HIV-infected pregnant women receiving antiretroviral therapy independent of nevirapine exposure.

Item
http://www.wikidata.org/entity/Q37439907
Tuberculosis in pregnant and postpartum women: epidemiology, management, and research gapsTuberculosis and hepatic steatosis are prevalent liver pathology findings among HIV-infected patients in South AfricaAdverse events in a cohort of HIV infected pregnant and non-pregnant women treated with nevirapine versus non-nevirapine antiretroviral medicationMode of delivery and infant respiratory morbidity among infants born to HIV-1-infected womenUsing two on-going HIV studies to obtain clinical data from before, during and after pregnancy for HIV-positive women.The impact of HBV or HCV infection in a cohort of HIV-infected pregnant women receiving a nevirapine-based antiretroviral regimen in Malawi.Safety and tolerability of antiretrovirals during pregnancy.Pregnancy is associated with elevation of liver enzymes in HIV-positive women on antiretroviral therapy.Intrahepatic Cholestasis of Pregnancy and Serum Bile Acids in HIV-Infected Pregnant Women.Elevated alanine aminotransferase in antiretroviral-naïve HIV-infected African patients: magnitude and risk factors.Defining a reference set to support methodological research in drug safety.Nevirapine-associated toxicity in clinical practice in Buenos Aires, Argentina.Nevirapine-associated hepatotoxicity and rash among HIV-infected pregnant women in Kenya.
P2860

Increased risk of hepatotoxicity in HIV-infected pregnant women receiving antiretroviral therapy independent of nevirapine exposure.

Item
http://www.wikidata.org/entity/Q37439907
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Increased risk of hepatotoxici ...... endent of nevirapine exposure.
@en
Increased risk of hepatotoxici ...... endent of nevirapine exposure.
@nl
type
label
Increased risk of hepatotoxici ...... endent of nevirapine exposure.
@en
Increased risk of hepatotoxici ...... endent of nevirapine exposure.
@nl
prefLabel
Increased risk of hepatotoxici ...... endent of nevirapine exposure.
@en
Increased risk of hepatotoxici ...... endent of nevirapine exposure.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Increased risk of hepatotoxici ...... endent of nevirapine exposure.
@en
P2093
P2860
P304
P31
P356
10.1097/QAD.0B013E32832E34B1
P407
P433
P478
P50
P577
P5875
P698
P921
P932